Latest stories
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
The FDA requires all GLP-1 drugs, including Ozempic and Mounjaro, to warn of potential NAION risk, a rare condition causing sudden vision…
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
Genfit advances TREM-1 modulator into ACLF after prior Phase 2 trials showed safety signals in septic shock and severe COVID-19.
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
Large population study finds SABR linked to higher three-year mortality than surgery, but gap narrows significantly for patients 80 and older.
-
Study Finds Autistic Adults Over 45 Face Nearly Triple Parkinsonism Rates
A U.S. Medicare analysis shows Parkinsonism prevalence of 3.8% in autistic seniors versus 1.6% in peers, highlighting new neurodegenerative risks for the…
-
Why Former Firefighters Face Lingering Psychological Trauma After Leaving the Career
An exploration of how leaving high-stress emergency services impacts mental health, reopening deep psychological wounds during secondary trauma events.
-
UNICORN Trial Finds Deep Responses to Preoperative Immunotherapy
New data from Agenus’ UNICORN trial reveals that short-course neoadjuvant immunotherapy achieves pathologic complete responses in 93% of dMMR colon cancer patients,…
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
New research suggests that consuming sugary foods more than twice a week is associated with a significant increase in breast cancer incidence.
-
Generic HIV Shot Cuts Cost to $40, Unlocking Access in 120 Low-Income Countries
FDA approval of Dr. Reddy’s lenacapavir generic enables affordable, twice-yearly HIV prevention for millions in developing regions.
-
Major study links moderate alcohol consumption to increased cancer risk and early death
Even one drink a day raises risk of cancer, heart disease and premature death, researchers say, challenging the idea that moderate drinking…
-
Ractigen Launches Phase II Trial for Bladder Cancer Treatment
Ractigen Therapeutics initiates Phase II clinical trial for saRNA therapy RAG-01 to treat non-muscle invasive bladder cancer in China.
-
Flawed Studies Prompt Hormone Therapy Caution for Breast Cancer Survivors
Recent reevaluations of past studies suggest hormone therapy may be safer for breast cancer survivors than previously thought, but doctors remain cautious.
-
Great Lakes: Over 6,400 Oil Spills Over a Decade
A new study reveals thousands of small oil spills in the Great Lakes, raising concerns about their long-term ecological impact.
-
October FDA Approvals Beyond Cancer: Hives, Schizophrenia, Eye Disease, Hepatitis B and Crohn Disease
From allergy to ophthalmology, new October treatments bring first-in-class options and at-home therapies for chronic conditions and rare diseases.
-
How New Immunotherapy Aims to Break the Cycle of Surgery for RRP Patients
The FDA has approved VOCERYQ, a novel DNA-based immunotherapy designed to reduce the need for repeated surgical interventions in adults with RRP.
-
FDA Approves Tirzepatide to Reduce Heart Attack Risk in Type 2 Diabetes
The FDA has approved tirzepatide (Mounjaro) for cardiovascular risk reduction, marking a shift from glucose-only control to comprehensive heart protection based on…
-
RFK Jr. Orders FDA to Allow Unapproved Peptide Injections
Health Secretary Robert F. Kennedy Jr. orders the FDA to halt enforcement on six unapproved wellness peptides, prompting safety concerns from scientists…
-
New Study Shows Tucatinib Delays Progression in Breast Cancer Spread to Brain
A Duke-led trial found adding tucatinib to standard care substantially delayed worsening in HER2-positive breast cancer patients with new brain metastases.
-
FDA Draft Guidance Would Let Individualized Gene Editing Variants Share One License Application
New regulatory framework aims to streamline submissions for multiple gene therapy variants under a single application, addressing critical gaps in oversight for…
-
GSK to Nearly Double Cancer Drugs in Trials as It Rebuilds Oncology Ahead of HIV Patent Cliff
Amidst looming patent expirations for HIV blockbusters, GSK is aggressively expanding its oncology pipeline, aiming to double late-stage cancer drug studies by…
-
Legal Battles Over Cancer Funding Delay Life-Saving Care for Patients
Court rulings on liability and funding disputes force patients to wait years for verdicts, while Medicare recovery rules threaten to consume settlement…
-
Stanford Digital Twins Point to a Drug Pair That May Delay Preterm Labor
Researchers use immune system simulations to find a drug pair that delays labor 15 times better than aspirin alone, offering hope for…
-
Why Microsatellite Instability Status Dictates Rectal Cancer Treatment Choices
MSI-H status identifies rectal cancer patients who may avoid surgery via dostarlimab, a new FDA-approved immunotherapy targeting defective DNA repair.
-
Why KRAS Was Considered Undruggable for Decades and What Finally Cracked It
A smooth protein surface and high GTP affinity stymied drugmakers until a cysteine at G12C enabled covalent inhibitors like divarasib.
-
Fulvic Acid and Cancer: What the 14-Hour Melanoma Study Actually Found
A viral reel cites a 2022 lab study on melanoma cells. Here is what it tested, what it found and what it…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992